|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 655 K Street NW, Suite 100 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20001-2399 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 4493-12
|
||||||||
|
6. House ID# 312430000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Leonard Marquez |
Date | 1/22/2024 1:06:38 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Issue: Support research with non-human primates
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Presidents FY 2024 Budget Request
S.2624 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024
H.R.5894 - House FY 2024 Labor, Health and Human Services, and Education, and related agencies spending bill
Issues: Support increased funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), Hospital Preparedness Program, and biodefense, emerging special pathogens and public health preparedness programs. Support mandatory funding for public health preparedness. Oppose limitations on facilities and administrative reimbursement and on salary support. Maintain NIH salary cap at Executive Level II. Support animal research and oppose efforts to increase burden on researchers unnecessarily. Ensure investment in Advanced Research Projects Agency for Health (ARPA-H) does not supplant NIH funding. Oppose arbitrary restrictions on specific types and sites of research. Support reproductive health training; and diversity, equity, and inclusion efforts. Support funding for Health Resources and Services Administration (HRSA) workforce programs. Support funding for CDC Social Determinants of Health program (SDOH), Prevention Research Centers, hospital-based and community violence interventions, data modernization, outbreak forecasting, and climate and health, and gun violence prevention research. Support funding to combat opioid epidemic. Support ongoing investment in public health infrastructure. Support funding for maternal health. Support expansion of CDC-supported genomic sequencing. Support robust 302(b) allocation. Support funding for Hepatitis-C proposal.
H.R.5893 - House FY 2024 Commerce and Justice, Science, and Related Agencies Spending Bill
S.2321 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024
Issue: Support funding for the National Science Foundation.
H.R.4366/S.2127 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024
H.R.4366 - Consolidated Appropriations Act, 2024
Issue: Support funding for the VA medical and prosthetic research program.
H.R.4821/S.2605 - Department of the Interior, Environment, and Related Agencies Appropriations Act, 2024
Issue: Support funding for Indian Health Service workforce programs, including graduate medical education partnerships with academic medical centers.
Issue: Ensure robust non-defense discretionary spending levels.
P.L.118-5 - Fiscal Responsibility Act of 2023
Issue: Oppose cuts to discretionary spending.
S.862 - Restoring Americas Health Care Workforce and Readiness Act
Issue: Support extension of National Health Service Corps funding.
Issue: Support extension of funding for Teaching Health Centers and the National Health Service Corps.
Issue: Support providing discretionary funds for rural teaching hospitals to expand their residency programs.
P.L.118-15 - Continuing Appropriations Act, 2024 and Other Extensions Act
P.L.118-22 - Further Continuing Appropriations and Other Extensions
Issue: Support continuation of federal funding.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Katherine |
Cruz |
|
|
|
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Andrea |
Price-Carter |
|
|
|
Danielle |
Turnipseed |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Draft Higher Education Act Reauthorization
Issues: Support affordable income driven repayment plans for borrowers. Oppose cuts to graduate/professional student loan and repayment plans, including Public Service Loan Forgiveness, and elimination of GradPLUS loans.
H.R.4985/S.3175 - Expanding Medical Education Act
Issue: Support grants to create, expand, and support medical schools and regional medical campuses, including MSIs.
Draft Pathway to Practice Act
Issue: Support Pathway to Practice medical school scholarships and GME positions for underrepresented students.
Draft National Medical Corps Act
Issue: Support improving the pathway from community college to careers in medicine.
Issue: Educate Congress and the administration on the impact of medical education debt on career decisions like specialty choice.
Issue: Educate Congress on the role academic medicine can serve with the Commission on the Social Status of Black Men and Boys.
Issue: Support the elimination of taxes on non-tuition student scholarship and grant aid.
H.R.6585 - Bipartisan Workforce Pell Act
Issue: Oppose limiting financial aid access for students at institutions subject to the endowment tax.
H.R.6077 - Protecting Our Students by Terminating Graduate Rates that Add to Debt (POST GRAD) Act
Issue: Support reinstating graduate student eligibility for Federal Direct Subsidized Loans.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Danielle |
Turnipseed |
JD |
|
|
Tannaz |
Rasouli |
|
|
|
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Katherine |
Cruz |
|
|
|
Andrea |
Price-Carter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R.3046/S.1403 - Medical Student Education Authorization Act of 2023
Issue: Support grants for primary care training in medically under-resourced communities.
Draft Social Determinants Accelerator Act
Issue: Support grants to address social determinants of health.
Draft Health Equity and Accountability Act
Issue: Support programs to improve health equity and address social determinants of health.
S.2333 - Pandemic and All-Hazards Preparedness and Response Act
H.R.4420 - Preparedness and Response Reauthorization Act
H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act
H.R.4697 - Protecting PAHPA Act of 2023
Issues: Support the reauthorization of the Pandemic and All-Hazards Preparedness Act with increased funding authorization levels.
Issue: Support authorities to strengthen CDCs and ASPRs ability to prevent and respond to existing and emerging threats.
Issue: Responded to request for information on CDC modernization.
S.1995 - Public Health Infrastructure Saves Lives Act
Issue: Support investments in core public health infrastructure.
Issue: Educate Congress on how the 340B Drug Pricing Program helps safety-net providers to fulfill their missions and care for patients and communities. Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, restrict use of contract pharmacies, and impose additional reporting requirements for 340B hospitals.
H.R.2534 - Preserving Rules Ordered for the Entities Covered Through 340B Act of 2023 (PROTECT 340B Act)
Issue: Support measures to prevent pharmacy benefit managers and commercial insurers from imposing discriminatory reimbursement policies on 340B covered entities.
H.R.3561 - Promoting Access to Treatments and Extremely Needed Transparency Act of 2023 (PATIENT Act) Issue: Oppose requiring 340B covered entities to report their 340B savings for patients enrolled in Medicaid managed care plans. Oppose implementation of so-called site-neutral payment policies in the Medicare program. Oppose burdensome and duplicative reporting and transparency requirements.
Issue: Educate Congress about the impacts of drug shortages on academic medical centers and the patients they serve. Support measures to address drug shortages and strengthen the pharmaceutical supply chain.
H.R.3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.
Issue: Oppose efforts to impose additional, onerous reporting requirements on 340B hospitals.
Issue: Oppose insurance plans that do not meet Affordable Care Act requirements.
Issue: Support policies to improve maternal health outcomes through expanded Medicaid coverage, enhanced data collection, and improved access to behavioral health care during the perinatal period.
H.R.3838/S.2415 - Preventing Maternal Deaths Reauthorization Act
Issue: Support continued federal funding for state-based maternal mortality review committees.
H.R.2369 - Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023
Issue: Educate Congress on development of Laboratory Developed Tests at academic medical centers and oppose policies that would increase burdensome regulations and negatively impact patients access to care by allowing FDA regulation of the development of Laboratory Developed Tests at academic medical centers.
Issue: Educate Congress on the medical education and training continuum, the annual residency Match, and the role of the National Resident Matching Program (NRMP) in medical education and residency.
Issue: Provide guidance on the implementation of the No Surprises Act (P.L.116-260).
Issue: Educate Congress and the administration on the role of academic medicine in the provision of mental and behavioral health care, including initiatives to respond to the opioid epidemic. Support policies to strengthen the behavioral health workforce, promote the uptake of integrated behavioral health models, advance mental health research, and ensure access to coverage and care.
Issue: Educate Congress about the financial challenges facing academic medical centers, including reimbursement challenges, workforce challenges, inflation, and others.
Issue: Educate Congress and the administration about the impact of the unwinding of the COVID-19 public health emergency on the academic medicine community and the patients they serve.
S.2840 - Bipartisan Primary Care and Health Workforce Act
Issue: Oppose cuts to the Prevention and Public Health Fund. Support workforce investments and extension of National Health Service Corps funding.
H.R.3887 - Childrens Hospital GME Support Reauthorization Act of 2023
H.R.3841 - To amend title III of the Public Health Service Act to reauthorize the program of payments to children's hospitals that operate graduate medical education programs
Issue: Urge clean reauthorization of the Childrens Hospital GME program.
Issue: Express concern regarding actions to inappropriately undermine FDA regulatory authority.
Issue: Educate Congress and the administration about medical education on nutrition, hunger, and health; reproductive health; substance use disorders; medication assisted treatment for opioid use disorders; trans health; preventing fraud and abuse; diversity, equity, and inclusion; menopause management; and health care for people with disabilities.
P.L.118-31 - National Defense Authorization Act for Fiscal Year 2024
Issue: Support military health workforce.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Executive Office of the President (EOP), Office of Natl Drug Control Policy (NDCP), Drug Enforcement Administration (DEA), Office of Science & Technology Policy (OSTP), Agency for Healthcare Research & Quality (AHRQ), White House Office, Vice President of the U.S., Natl Security Council (NSC), Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Sinead |
Hunt |
|
|
|
Katherine |
Cruz |
|
|
|
Tannaz |
Rasouli |
|
|
|
Danielle |
Turnipseed |
JD |
|
|
Andrea |
Price-Carter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
S.665/H.R.4942 - Conrad State 30 and Physician Access Reauthorization Act
H.R.4875 - Doctors in our Borders Act
Issue: Expansion of the Conrad 30 program and improvements to physician immigration.
Issue: Educate Congress on policies allowing undocumented students to attend U.S. medical schools and graduate medical education.
S.3211 - Healthcare Workforce Resilience Act
Issue: Support reduction of green card backlogs for health professionals.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Tannaz |
Rasouli |
|
|
|
Katherine |
Cruz |
|
|
|
Ally |
Perleoni |
|
|
|
Andrea |
Price-Carter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Issue: Educate Congress and the administration about the impact of regulatory burden on medical research.
Issue: Educate Congress and the administration about preparedness and lab safety for pathogens with pandemic potential.
Issue: Support the nomination of Monica Bertagnolli to be NIH Director.
Issue: Support the role of academic medical centers in engaging with ARPA-H.
Issue: Responded to request for information on NIH.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office, Executive Office of the President (EOP), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Danielle |
Turnipseed |
JD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R.2389/S.1302 - Resident Physician Shortage Reduction Act of 2023
Issue: Support increased Medicare funding for graduate medical education (GME).
H.R.751 - Fair Access in Residency Act
Issue: Oppose legislative interference in residency training program requirements and policies requiring the Medicare program to consider specific physician licensing exams for residency program applications.
S.230/H.R.834 - Rural Physician Workforce Production Act
Issue: Oppose legislation redesigning Medicare GME payment formulas that reduce current DGME/IME payments to teaching hospitals.
S.2768/H.R.2584 - Safety From Violence for Healthcare Employees (SAVE) Act
Issue: Support legislation providing protection for health care workers by creating a criminal offense for knowingly assaulting or intimidating hospital workers and providing grants to reduce violence in hospitals.
H.R.5378 - Lower Costs, More Transparency Act
Issue: Oppose legislation that pays for workforce investments and mitigation of DSH cuts if it is paid for by cuts to hospital outpatient departments.
H.R.5013 - Value in Health Care Act
Issue: Support legislation that ensures the continued move to value-based care.
H.R.2474 - Strengthening Medicare for Patients and Providers Act
Issue: Support legislation that reforms the Medicare Physician Fee Schedule by providing an annual inflation-based payment update based on the Medicare Economic Index (MEI).
Issue: Provide feedback to CMS and Congress on CMS distribution of the 1,000 new GME slots authorized by the Consolidated Appropriations Act, 2021 (P.L.116-260). Support CMS changing its distribution methodology to end the practice of super prioritization.
Issue: Support Medicare GME per resident amount and cap-setting technical corrections and administrative relief.
Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments.
Issue: Oppose reduction of Medicare GME/IME payments.
Issue: Oppose the redesign of Medicare Indirect Medical Education financing and redistribution.
Issue: Oppose establishing nationality-based restrictions on medical residencies supported by Medicare.
Issue: Oppose reduction in Medicare hospital outpatient department reimbursement for drug administration and other services.
Issue: Oppose site-neutral expansion to excepted off-campus provider-based departments (PBDs).
Issue: Oppose Medicare hospital, physician, and provider cuts.
Issue: Educate Congress on role of academic medicine as it relates to price transparency or disclosure initiatives.
Issue: Protect patients from delays in care by streamlining and standardizing prior authorization under the Medicare Advantage program and providing program oversight and transparency.
Issue: Support necessary changes and improvements to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
Issue: Educate Congress and policymakers on the financial challenges facing teaching hospitals and health systems, medical schools, and faculty practices and the impact on patients access to care and the nations health.
Issue: Support delaying or eliminating scheduled cuts to the Medicaid disproportionate share hospital (DSH) program.
H.R.2665 - The Supporting Safety Net Hospitals Act
Issue: Support eliminating two years worth of scheduled reductions to the Medicaid DSH program.
Issue: Support policies to close the Medicaid coverage gap and ensure access to coverage in non-expansion states, as well as financial incentives to help states maintain existing expansions. Support mandatory 12-month Medicaid coverage for post-partum individuals.
Issue: Oppose efforts by states to impose work or other community engagement activities as a requirement for continued Medicaid eligibility or coverage for certain Medicaid beneficiaries.
Issue: Support waiving budget neutrality requirements associated with the E/M code changes or temporarily holding harmless physicians and other health care professionals.
Issue: Support permanent extension of Medicare telehealth waivers.
Issue: Support extension of Acute Hospital at Home program waiver of 24/7 nursing requirement.
Issue: Support permanent extension of current Covid telehealth flexibilities.
Issue: Support efforts to expand patient access to telehealth.
H.R.1397 - The Telehealth Improvement for Kids Essential Services Act
Issue: Support providing states with guidance to increase telehealth access in Medicaid and CHIP.
Issue: Support increased access to behavioral health and substance use disorder treatment services under Medicare and Medicaid. Support the removal of regulatory barriers to telehealth-enabled mental health care, including electronic interprofessional consults (eConsults).
Issue: Support policy to permanently remove requirement for Medicare beneficiaries to be seen in-person every six months for telehealth visits for mental health services.
Issue: Support creation of new Medicare outpatient IME payment in addition to existing Medicare IME payment inpatient methodology. Oppose policies to create budget neutral IME payments for outpatient services.
Issue: Support extension of alternative payment model (APM) bonus.
H.R.2377/S.1000 - The Saving Access to Laboratory Services (SALSA) Act
Issue: Support legislation to modify Medicare payment rates for clinical diagnostic laboratory services to avoid statutory cuts to these payments.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Sinead |
Hunt |
|
|
|
Tannaz |
Rasouli |
|
|
|
Danielle |
Turnipseed |
JD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, and education partnerships.
Issue: Discuss opportunities to support local affiliations between academic medical centers and VA medical centers.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Danielle |
Turnipseed |
JD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issue: support preservation of nonprofit tax status for AAMC member teaching health systems and hospitals with federal nonprofit status.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Ally |
Perleoni |
|
|
|
Sinead |
Hunt |
|
|
|
Danielle |
Turnipseed |
JD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |